147 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
accountings, inadequate corporate governance and ineffective implementation thereof and, in many cases, allegations of fraud. As a result of enhanced … of the Nasdaq Capital Market, such as the corporate governance requirements or the minimum closing bid price requirement, the Nasdaq Capital Market may take
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
, inadequate corporate governance and ineffective implementation thereof and, in many cases, allegations of fraud. As a result of enhanced scrutiny, criticism … , such as the corporate governance requirements or the minimum closing bid price requirement, the Nasdaq Capital Market may take steps to delist our common
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
Item 9C.
Disclosure Regarding Foreign Jurisdictions That Prevent Inspections
Part III
Item 10.
Directors, Executive Officers and Corporate Governance … internal control over financial accountings, inadequate corporate governance and ineffective implementation thereof and, in many cases, allegations
424B4
o53bh5vze8a3zlicv6vn
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
8qcum9qyu
17 Nov 23
Prospectus supplement
5:00pm
424B4
nxqakekvwhd
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
hwqvqcmqp7nn5f 62vci
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B3
gm8drg4uok
17 Aug 23
Prospectus supplement
5:00pm
424B4
9mu5hx138e
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B5
brkjw9m5dv4zqzo
31 Jul 23
Prospectus supplement for primary offering
9:01am
424B4
mwfbkohz0
12 Jun 23
Prospectus supplement with pricing info
4:30pm